Wealthcare Advisory Partners LLC Sells 481 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Wealthcare Advisory Partners LLC reduced its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 9.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 4,697 shares of the company’s stock after selling 481 shares during the quarter. Wealthcare Advisory Partners LLC owned approximately 0.05% of iShares U.S. Pharmaceuticals ETF worth $331,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of IHE. Captrust Financial Advisors boosted its holdings in iShares U.S. Pharmaceuticals ETF by 3.5% in the fourth quarter. Captrust Financial Advisors now owns 5,025 shares of the company’s stock worth $330,000 after acquiring an additional 171 shares in the last quarter. HighTower Advisors LLC increased its stake in shares of iShares U.S. Pharmaceuticals ETF by 1.9% in the fourth quarter. HighTower Advisors LLC now owns 13,653 shares of the company’s stock worth $897,000 after purchasing an additional 261 shares in the last quarter. Advisory Services Network LLC lifted its holdings in iShares U.S. Pharmaceuticals ETF by 7.1% during the 4th quarter. Advisory Services Network LLC now owns 4,439 shares of the company’s stock worth $292,000 after purchasing an additional 293 shares in the last quarter. Orion Portfolio Solutions LLC boosted its holdings in iShares U.S. Pharmaceuticals ETF by 3.2% in the 4th quarter. Orion Portfolio Solutions LLC now owns 10,465 shares of the company’s stock valued at $688,000 after purchasing an additional 321 shares during the period. Finally, Atala Financial Inc bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter worth approximately $25,000.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of NYSEARCA:IHE opened at $67.50 on Friday. The firm has a market capitalization of $573.75 million, a price-to-earnings ratio of 22.74 and a beta of 0.56. iShares U.S. Pharmaceuticals ETF has a one year low of $58.97 and a one year high of $73.28. The company’s fifty day moving average price is $64.85 and its 200-day moving average price is $67.26.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.